1 Min Read
Oct 5 (Reuters) - Interpace Diagnostics Group Inc :
* Interpace Diagnostics announces New York state approval of thygenx for indeterminate thyroid nodules Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.